The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)

BACKGROUND: The Glivec International Patient Assistance Program (GIPAP) is a unique direct-to-patient program that provides imatinib (Glivec) at no cost to eligible patients in low- and middle-income countries (LMICs) with chronic myelogenous leukemia (CML) or gastrointestinal stromal tumor (GIST)....

Descripción completa

Detalles Bibliográficos
Autores principales: Umeh, Chukwuemeka A., Garcia-Gonzalez, Pat, Tremblay, David, Laing, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046500/
https://www.ncbi.nlm.nih.gov/pubmed/32140674
http://dx.doi.org/10.1016/j.eclinm.2020.100257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046500/
https://www.ncbi.nlm.nih.gov/pubmed/32140674
http://dx.doi.org/10.1016/j.eclinm.2020.100257

Ejemplares similares